Patrick M. Travis

Combined Chemoradiotherapy Regimens of Paclitaxel and Carboplatin for Locally Advanced Non–Small-Cell Lung Cancer: A Randomized Phase II Locally Advanced Multi-Modality Protocol

Chandra P. Belani, Hak Choy, P. Bonomi et al. · Journal of Clinical Oncology · 2005 · 428 citations

Medicine, Oncology, Radiation Oncology +16

Ublituximab plus ibrutinib versus ibrutinib alone for patients with relapsed or refractory high-risk chronic lymphocytic leukaemia (GENUINE): a phase 3, multicentre, open-label, randomised trial

Jeff P. Sharman, Danielle M. Brander, Anthony R. Mato et al. · The Lancet Haematology · 2021 · 50 citations

Medicine, Hematology, Oncology +13

O-263 Randomized 3-arm phase II study of paclitaxel (T), carboplatin (C), and thoracic radiation (TRT) for patients with stage III non-small cell lung cancer (NSCLC). Report of locally advanced multimodality protocol (LAMP) - ACR 427

P. Bonomi, Walter J. Curran, Hak Choy et al. · Lung Cancer · 2003 · 45 citations

Medicine, Oncology, Radiation Oncology +13

Mode of chemotherapy does not affect complications with an implantable venous access device

Danielle F. Brown, Michael Muirhead, Patrick M. Travis et al. · Cancer · 1997 · 36 citations

Medicine, Oncology, Surgery +17

An Effective Personalized Approach to a Rare Tumor: Prolonged Survival in Metastatic Pancreatic Acinar Cell Carcinoma Based on Genetic Analysis and Cell Line Development

Matthew D. Armstrong, Daniel D. Von Hoff, Bruce W. Barber et al. · Journal of Cancer · 2011 · 29 citations · Full text

Medicine, Molecular Medicine, Oncology +17